Pfizer (PFE) Said to Plan IPO of Animal-Health Unit in Early FY13
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $25.06 -0.32%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
Revenue Growth %: -1.9%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
Revenue Growth %: -1.9%
Join SI Premium – FREE
Pfizer (NYSE: PFE) shares are ticking higher in late trading Thursday, amid new talk surrounding the IPO of Zoetis.
According to the WSJ, Pfizer is planning to take Zoetis -- Pfizer's animal0-health unit -- public in January or February 2013. The IPO is expected to price somewhere around $4 billion.
Pfizer is running low on options for Zoetis; its $20 billion valuation is priced out of many potential buyers range. Pfizer attempted to divest the unit last year, saying animal-heath products didn't gel with its human-health focus.
Shares are modestly higher after hours.
According to the WSJ, Pfizer is planning to take Zoetis -- Pfizer's animal0-health unit -- public in January or February 2013. The IPO is expected to price somewhere around $4 billion.
Pfizer is running low on options for Zoetis; its $20 billion valuation is priced out of many potential buyers range. Pfizer attempted to divest the unit last year, saying animal-heath products didn't gel with its human-health focus.
Shares are modestly higher after hours.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer temporarily discontinues premarin vaginal cream in India, citing supply challenges - Reuters
- Meta Platforms (META) in talks to lease compute to Anthropic - NYT
- Deepseek Is Said To Prepare For Ipo Filing As Soon As This Year - Bloomberg
Create E-mail Alert Related Categories
IPOs, Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
